The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness Research Peptides In Minnesota: Why Not For Human Consumption Doesn't Protect You Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law